Ameritas Investment Partners’s Corbus Pharmaceuticals CRBP Stock Holding History

Ameritas Investment Partners’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14K	Buy	+1,494	New	+$14.1K	﹤0.01%	2917
2025 Q2	–	Sell	-996	Closed	-$5.29K	–	3230
2025 Q1	$5.29K	Hold	996	–	–	﹤0.01%	2960
2024 Q4	$11.8K	Hold	996	–	–	﹤0.01%	2858
2024 Q3	$20.5K	Hold	996	–	–	﹤0.01%	2645
2024 Q2	$45.1K	Buy	+996	New	+$41.9K	﹤0.01%	2199
2021 Q2	–	Sell	-167	Closed	-$10K	–	3092
2021 Q1	$10K	Hold	167	–	–	﹤0.01%	2856
2020 Q4	$6K	Hold	167	–	–	﹤0.01%	2933
2020 Q3	$9K	Hold	167	–	–	﹤0.01%	2756
2020 Q2	$42K	Hold	167	–	–	﹤0.01%	1935
2020 Q1	$26K	Buy	167 +37	+28%	+$6.25K	﹤0.01%	2027
2019 Q4	$21K	Hold	130	–	–	﹤0.01%	2385
2019 Q3	$19K	Hold	130	–	–	﹤0.01%	2413
2019 Q2	$27K	Hold	130	–	–	﹤0.01%	2262
2019 Q1	$27K	Hold	130	–	–	﹤0.01%	2219
2018 Q4	$23K	Hold	130	–	–	﹤0.01%	2257
2018 Q3	$29K	Hold	130	–	–	﹤0.01%	2304
2018 Q2	$20K	Hold	130	–	–	﹤0.01%	2507
2018 Q1	$24K	Hold	130	–	–	﹤0.01%	2320
2017 Q4	$28K	Hold	130	–	–	﹤0.01%	2263
2017 Q3	$30K	Hold	130	–	–	﹤0.01%	2185
2017 Q2	$24K	Buy	+130	New	+$25.5K	﹤0.01%	2353

Other funds holding CRBP

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JHC

Jones Hill Capital New York $470M AUM

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Ameritas Investment Partners's CRBP Position: Q2 2026 in Review

Ameritas Investment Partners opened a new position in Corbus Pharmaceuticals (CRBP) in Q2 2026: 1,494 shares worth $14K. The stake represents ﹤0.01% of the portfolio and ranks #2917 among its holdings. This is a return to the name: Ameritas Investment Partners previously reported a position in CRBP as recently as Q1 2025.

Ameritas Investment Partners first reported a position in CRBP in Q2 2017 and has held it in 21 quarters since. The position peaked at $45.1K in Q2 2024. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

Ameritas Investment Partners held 1,494 shares of Corbus Pharmaceuticals worth $14K as of Q2 2026.
Corbus Pharmaceuticals was a new Ameritas Investment Partners position in Q2 2026.
Corbus Pharmaceuticals made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2917 holding.
Ameritas Investment Partners first reported a position in Corbus Pharmaceuticals in Q2 2017 and has held it in 21 quarters since.
Ameritas Investment Partners's Corbus Pharmaceuticals position peaked at $45.1K in Q2 2024.
107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.